Unia Europejska - słoweński - EMA (European Medicines Agency)

astellas pharma europe b.v. - gilteritinib fumarate - leukemija, myeloid, akutna - antineoplastična sredstva - xospata je označen kot monotherapy za zdravljenje odraslih bolnikov, ki so relapsed ali ognjevzdržni akutno mieloično levkemijo (aml), z flt3 mutacija.

Unia Europejska - słoweński - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , trojna kombinacija terapija), kot dodatek k prehrani in vadbi pri bolnikih neustrezno nadzorovano na maksimalno dopustne odmerek metforminom in sulfonil sečnine. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - bisoprolol - filmsko obložena tableta - bisoprolol 2,12 mg / 1 tableta - bisoprolol

Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - bisoprolol - filmsko obložena tableta - bisoprolol 8,49 mg / 1 tableta - bisoprolol

Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - bisoprolol - filmsko obložena tableta - bisoprolol 1,06 mg / 1 tableta - bisoprolol

Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - bisoprolol - filmsko obložena tableta - bisoprolol 4,24 mg / 1 tableta - bisoprolol

Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bisoprolol - filmsko obložena tableta - bisoprolol 2,12 mg / 1 tableta - bisoprolol

Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bisoprolol - filmsko obložena tableta - bisoprolol 4,24 mg / 1 tableta - bisoprolol

Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bisoprolol - filmsko obložena tableta - bisoprolol 1,06 mg / 1 tableta - bisoprolol

Unia Europejska - słoweński - EMA (European Medicines Agency)

novartis europharm ltd - aliskiren, amlodipine - hipertenzija - sredstva, ki delujejo na sistem renin-angiotenzin - zdravilo rasilamlo je indicirano za zdravljenje esencialne hipertenzije pri odraslih bolnikih, pri katerih krvni tlak ni ustrezno nadzorovan z uporabo aliskirena ali amlodipina.